These data are consistent with our recent demonstration that glycolytic cancer cells are more prone to control MG toxicity than less glycolytic cancer cells, notably through the expression of elevated levels of both GLO1 and its cognate transcriptional regulator Nrf2 [9]. Here, GLO1 is linked to cancer.